Arcutis Biotherapeutics (ARQT) Debt/EBITDA US GAAP (year values)

2020 2021 2021 2022 2023   LTM ? CAGR 5 years ?
Debt/EBITDA 2.07 1.50 1.51 0.70 0.29   0.90  
Changes by years, y/y, % -14% -27% +0% -53% -59%     -35.4%

Arcutis Biotherapeutics. Debt/EBITDA

Arcutis Biotherapeutics. Debt/EBITDA, changes, %

Arcutis Biotherapeutics (ARQT) Debt/EBITDA US GAAP (quarter values)

2023Q4 2024Q1 2024Q1 2024Q2 2024Q3   LTM ?
Debt/EBITDA 0.29 1.04 1.21 0.95 0.75   0.90
Changes by years, y/y, % -58% +147% +187% +349% +701%    
Changes by quarters, q/q, % +213% +256% +16% -21% -21%    

Arcutis Biotherapeutics. Debt/EBITDA

Arcutis Biotherapeutics. Debt/EBITDA, changes, y/y, %

Arcutis Biotherapeutics. Debt/EBITDA, changes, q/q, %